“Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history” - authors’ reply

European Journal of Preventive Cardiology · Published 2026-07-28 · DOI 10.1093/eurjpc/zwag403

Authors (3)

Sam-Lennart Oftadeh, Dirk Müller-Wieland, Marlo Verket

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Oftadeh, S., Müller-Wieland, D., Verket, M. (2026). “Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history” - authors’ reply. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwag403

Related articles

• Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history · European Journal of Preventive Cardiology · 2026 · Cites or is cited by this article · Same journal
• The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention · European Journal of Preventive Cardiology · 2026 · Same journal
• Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank · European Journal of Preventive Cardiology · 2026 · Same journal
• Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study · European Journal of Preventive Cardiology · 2026 · Same journal
• Beyond Survival: The Eriksen Case and the Dilemma of Elite Sport Participation After Sudden Cardiac Arrest · European Journal of Preventive Cardiology · 2026 · Same journal
• Cardiovascular prevention in childhood and young adults · European Journal of Preventive Cardiology · 2026 · Same journal
• Rethinking how we characterize the exercise blood pressure response in athletes · European Journal of Preventive Cardiology · 2026 · Same journal
• Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease · European Journal of Preventive Cardiology · 2026 · Same journal
• Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention · European Journal of Preventive Cardiology · 2026 · Same journal
• Safe hearts need a healthy environment: prevention beyond our clinic walls · European Journal of Preventive Cardiology · 2026 · Same journal